No Data
Cognition Therapeutics CEO Participating in Longwood and Sachs Conferences
B.Riley Financial Upgrades Cognition Therapeutics(CGTX.US) to Buy Rating, Raises Target Price to $1.5
Analysts Offer Insights on Healthcare Companies: Cognition Therapeutics (CGTX), Roche Holding AG (OtherRHHVF) and Incyte (INCY)
B. Riley Upgrades Cognition Therapeutics to Buy on Lewy Bodies Data
B. Riley Upgrades Cognition Therapeutics to Buy From Neutral, Lifts PT to $1.50 From $1
Cognition Therapeutics Is Maintained at Buy by Chardan Capital
Trytosaveabit : Very nicely done! Congrats Darlin
104942989 : This is insane to me. But well done 🫨
李飞Allyssa : I am really curious how long it took to accomplish.
103160675 : 3 hours ago, between 4:32-5:36 (while the price was 0.850). There was only 2 times the volume moved. At 4:32, 250. and at 5:37, 251.
Mr Brooks : wOw
View more comments...